Mortality among Urban Drug Users and the Impact of Highly Active Antiretroviral Therapy
Open Access
- 15 September 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 873-874
- https://doi.org/10.1086/432895
Abstract
HAART has been shown to improve the course of HIV disease by reducing viral load and increasing the CD4+ T lymphocyte count [1, 2]. Consequently, there have been decreases in the rate of progression to AIDS and subsequent significant decreases in the mortality rate [3]. Most of the published literature on the effectiveness of HAART on improved health status is restricted to white men, and only a few studies have directly addressed the survival benefit of HAART for injection drug users and women, who today constitute a substantial proportion of adults with HIV infection [4, 5].Keywords
This publication has 15 references indexed in Scilit:
- Mortality in an Urban Cohort of HIV-Infected and At-Risk Drug Users in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2005
- Mortality in HIV‐Seropositive versus ‐Seronegative Persons in the Era of Highly Active Antiretroviral Therapy: Implications for When to Initiate TherapyThe Journal of Infectious Diseases, 2004
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV DiseaseAnnals of Internal Medicine, 2001
- Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapyAIDS, 2001
- Marked Declines in Human Immunodeficiency Virus–Related Mortality in Chicago in Women, African Americans, Hispanics, Young Adults, and Injection Drug Users, From 1995 Through 1997Archives of internal medicine (1960), 2000
- A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and SurvivalJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection DurationJAMA, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug UsersNew England Journal of Medicine, 1989